topiramate

FDA Drug Profile — Topamax, topiramate, TOPIRAMATE, Trokendi XR

topiramate is listed in the FDA National Drug Code directory with 149 NDC codes, marketed under brand names including Topamax, topiramate, TOPIRAMATE. Available dosage forms: tablet, coated, tablet, film coated, powder, capsule, extended release, capsule, coated pellets.

Drug details

Generic Name
topiramate
Brand Names
Topamax, topiramate, TOPIRAMATE, Trokendi XR
Application Number
NDA020505
Sponsor
Janssen Pharmaceuticals, Inc.
NDC Codes
149
Dosage Forms
TABLET, COATED, TABLET, FILM COATED, POWDER, CAPSULE, EXTENDED RELEASE, CAPSULE, COATED PELLETS
Routes
ORAL
Active Ingredients
TOPIRAMATE

Indications and Usage

1 INDICATIONS AND USAGE Topiramate is indicated for: • Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 ); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2 ) • Preventive treatment of migraine in patients 12 years of age and older ( 1.3 ) 1.1 Monotherapy Epilepsy Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. 1.2 Adjunctive Therapy Epilepsy Topiramate tablets and topiramate capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. 1.3 Migraine Topiramate tablets and topiramate capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.